苏州近岸蛋白质科技股份有限公司关于持股5%以下股东减持股份计划公告

Group 1 - The core point of the announcement is that shareholders holding less than 5% of the company's shares plan to reduce their holdings due to operational and funding needs, with a reduction period starting three trading days after the announcement and lasting for three months [2][3]. - The shareholders involved in the reduction are Nanjing Jinli Venture Capital Partnership, Suzhou Jinling Venture Capital Partnership, and Shanghai Pujin Technology Development Partnership, collectively holding 140,111 shares, which is approximately 0.1997% of the total share capital [2]. - The reduction will be executed through methods such as centralized bidding and block trading, with the selling price determined by market conditions [2][3]. Group 2 - The shareholders have made commitments regarding their shareholding intentions and reduction plans, ensuring compliance with relevant laws and regulations, including a three-day prior notice before any reduction [3]. - The company confirms that the reduction plan will not lead to a change in control of the company and is consistent with previously disclosed commitments [4]. - The announcement emphasizes that the reduction plan aligns with the regulations set forth by the Shanghai Stock Exchange and other relevant authorities, ensuring that the shareholders will fulfill their disclosure obligations during the reduction period [4].

Novoprotein-苏州近岸蛋白质科技股份有限公司关于持股5%以下股东减持股份计划公告 - Reportify